At-line determination of pharmaceuticals small molecule's blending end point using chemometric modeling combined with Fourier transform near infrared spectroscopy.
This article summarizes the development and validation of a Fourier transform near infrared spectroscopy (FT-NIR) method for the rapid at-line prediction of active pharmaceutical ingredient (API) in a powder blend to optimize small molecule formulations. The method was used to determine the blend uniformity end-point for a pharmaceutical solid dosage formulation containing a range of API concentrations. A set of calibration spectra from samples with concentrations ranging from 1% to 15% of API (w/w) were collected at-line from 4000 to 12,500cm-1. The ability of the FT-NIR method to predict API concentration in the blend samples was validated against a reference high performance liquid chromatography (HPLC) method. The prediction efficiency of four different types of multivariate data modeling methods such as partial least-squares 1 (PLS1), partial least-squares 2 (PLS2), principal component regression (PCR) and artificial neural network (ANN), were compared using relevant multivariate figures of merit. The prediction ability of the regression models were cross validated against results generated with the reference HPLC method. PLS1 and ANN showed excellent and superior prediction abilities when compared to PLS2 and PCR. Based upon these results and because of its decreased complexity compared to ANN, PLS1 was selected as the best chemometric method to predict blend uniformity at-line. The FT-NIR measurement and the associated chemometric analysis were implemented in the production environment for rapid at-line determination of the end-point of the small molecule blending operation.
Pharmaceutical Analytical Department, Biogen, 115 Broadway, Cambridge, MA 02142, United States. Electronic address: jagdish.tewari@biogen.com.
Jagdish
J
Tewari
Pharmaceutical Analytical Department, Biogen, 115 Broadway, Cambridge, MA 02142, United States.
Richard
R
Strong
Pharmaceutical Analytical Department, Biogen, 115 Broadway, Cambridge, MA 02142, United States.
Pierre
P
Boulas
D002851:Chromatography, High Pressure Liquid / Q000379:methods; D008958:Models, Molecular; D004364:Pharmaceutical Preparations / Q000032:analysis* / Q000737:chemistry*; D017550:Spectroscopy, Fourier Transform Infrared / Q000379:methods
D004364:Pharmaceutical Preparations
Artificial neural network (ANN); Blend uniformity; Chemometric; FT-NIR; Figures of merit; Partial least squares (PLS1, PLS2); Principal component regression (PCR)